Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors. [electronic resource]
- Human vaccines Jun 2011
- 639-45 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1554-8619
10.4161/hv.7.6.15408 doi
AIDS Vaccines--immunology Adolescent Adult Africa Antibodies, Neutralizing--blood Antibodies, Viral--blood Cross Reactions Europe Female Genetic Vectors Humans Japan Male Middle Aged Parainfluenza Virus 1, Human--immunology Sendai virus--genetics United States